Ming Yang is CFO at China Biologic Products, Inc. (CBPO). They have made 8 open-market trades across 2 companies since 2014, most recently 2019-09-05.
CIK 0001369868
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $953K since 2019, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GURE | BUY | 2019-09-05 | 2019-09-06 | $0.72 | $953K | -49.5% | -8.7% | -8.7% |
| CBPO | SELL | 2016-08-15 | 2016-08-17 | $124.32 | $2.6M | -0.9% | +8.2% | +7.3% |
| CBPO | SELL | 2016-08-15 | 2016-08-17 | $124.32 | $2.6M | -0.9% | +8.2% | +7.3% |
| CBPO | SELL | 2016-05-20 | 2016-05-23 | $113.40 | $695K | +3.3% | -7.9% | +0.1% |
| CBPO | SELL | 2016-05-19 | 2016-05-23 | $113.83 | $885K | +3.3% | -7.9% | +0.1% |
| CBPO | SELL | 2016-05-19 | 2016-05-23 | $113.64 | $1.6M | +3.3% | -7.9% | +0.1% |
| CBPO | SELL | 2015-09-14 | 2015-09-16 | $95.96 | $1.9M | -15.1% | +2.2% | +2.2% |
| CBPO | SELL | 2014-09-12 | 2014-09-16 | $54.00 | $333K | -15.1% | +2.2% | +2.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.